Menlo Park, CA, Jan. 25, 2013 – The Anatomx Corporation announced today that veterinary surgeons and clinicians can now acquire leading-edge human medical devices for animal healthcare through its new online catalog at www.anatomx.com.
Initial product offerings include:
Advanced articulating radio frequency (RF) electrosurgical instrumentation that improves surgical access and reduces bleeding with greater agility and improved seals;
Resorbable, osteoconductive, antigenic bone void fillers that provide the compressive strength of cancellous bone while eliminating the risk of viral or organic contamination;
A novel wearable post-operative pain management system that allows animals freedom of movement while analgesic medication is delivered and monitored for up to 24-hours.
“Anatomx was established to help Veterinarians provide the best possible care — ultimately, to improve outcomes, and also to improve the clinical experience and recovery period for animal patients and their caregivers,” said Dr. Michael Sterns, Anatomx President and CEO. “We are also striving to help veterinary surgeons and clinicians improve their business models. For example, streamlining procedural workflows within the surgical suite and during recovery brings down overall costs for surgical procedures.
Anatomx also provides a new growth market for medical device manufacturers and developers, who can offer existing products in a non-conflicting channel, fulfilling the unmet needs of professionals serving a passionate, consumer-driven industry. Anatomx can help these companies realize incremental revenue for products already in their pipeline or in early commercialization without distracting them from their core business.
About Anatomx, Inc.
Anatomx is bringing the latest developments in human medical device technology to Veterinarians. Anatomx offers veterinary surgeons and clinicians minimally invasive, state-of-the-art veterinary innovations through its online catalog at www.anatomx.com. Founded by experienced Veterinarians with a track record of success in commercializing novel medical technologies, Anatomx works in close collaboration with veterinary specialists in both private practices and academic institutions, in order to improve outcomes for veterinary patients.
Further information is available at www.anatomx.com.
Michael Sterns, DVM
President & CEO
The Anatomx Corporation
+1 650 888 6406